POTS, ME/CFS and Long COVID: Recent Advances and Future Direction
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Immunology".
Deadline for manuscript submissions: 20 January 2026 | Viewed by 197
Special Issue Editor
Interests: neurology; autonomic disorders; POTS; long COVID; small fiber neuropathy; autoimmunity; immunotherapy; women’s health
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Postural orthostatic tachycardia syndrome (POTS), myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and long COVID are complex syndromes caused by or associated with the dysfunction of the autonomic nervous system, which can follow an acute infection. Disorders of the autonomic nervous system have been an evolving area of research and clinical practice. In the past 5 years, the SARS-CoV-2 pandemic further underscored the need to elucidate the autonomic mechanisms of post-acute infectious syndromes, such as POTS, ME/CFS and long COVID. To this end, understanding the pathophysiology of and developing diagnostic as well as therapeutic approaches for these three syndromes are critical to improving patient care; they also serve as an opportunity to lead to groundbreaking discoveries in all autonomic disorders and post-acute infectious syndromes. In this Special Issue of the Journal of Clinical Medicine, the aim is to collect papers on a variety of topics concerning POTS, ME/CFS and long COVID. Studies and reviews on the potential biomarkers and identification of effective diagnostic tests as well as therapeutic options in patients with these disorders are of particular interest.
We look forward to receiving your submissions to this Special Issue.
Dr. Svetlana Blitshteyn
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- POTS
- ME/CFS
- long COVID
- dysautonomia
- orthostatic intolerance
- autoimmunity
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
